Superior efficacy of oral ganciclovir over oral acyclovir for cytomegalovirus prophylaxis in kidney-pancreas and pancreas alone recipients.
Somerville
T
T
University of Tennessee College of Pharmacy and Medicine, Memphis, USA.
Hurst
G
G
Alloway
R
R
Gaber
A
A
Shokouh-Amiri
M H
MH
Stratta
R
R
D000212:Acyclovir / Q000008:administration & dosage / Q000627:therapeutic use*; D000284:Administration, Oral; D000328:Adult; D000998:Antiviral Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D003365:Costs and Cost Analysis; D003430:Cross-Sectional Studies; D003586:Cytomegalovirus Infections / Q000191:economics / Q000453:epidemiology / Q000517:prevention & control*; D015774:Ganciclovir / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D015994:Incidence; D016030:Kidney Transplantation; D016035:Pancreas Transplantation; D011183:Postoperative Complications; D012189:Retrospective Studies; D013714:Tennessee; D013997:Time Factors
D000998:Antiviral Agents; D015774:Ganciclovir; D000212:Acyclovir